Sol-Gel Technologies Ltd.
PHARMACEUTICAL COMPOSITIONS COMPRISING SILICA MICROSPHERES

Abstract:

Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.